Biopolym. Cell. 2001; 17(3):203-211.
http://dx.doi.org/10.7124/bc.0005AB
Огляди
Стовбурові клітини ссавців in vitro як основа для створення сучасних біотехнологій
1Лукаш Л. Л., 1Василовська С. В.
  1. Інститут молекулярної біології і генетики НАН України
    Вул. Академіка Заболотного, 150, Київ, Україна, 03680

Abstract

В огляді розглянуто основні напрямки досліджень з викори­станням стовбурових клітин людини і тварин: створення клітинних банків, вивчення властивостей поліпотентних стовбурових клітин і одержання імморталізованих клітинних ліній, роль ростових факторів та цитокінів у диференціюванні стовбурових клітин, клітинна терапія як альтернатива трансплантації органів, рекапітуляція ембріогенезу та клонування тварин.
Повний текст: (PDF, російською)

References

[1] Repin VS, Sukhih GT. Medical Cell Biology. M.: Izd-vo Ros. akad. med. nauk, 1998. 200 p.
[2] Johansson CB, Svensson M, Wallstedt L, Janson AM, Fris?n J. Neural stem cells in the adult human brain. Exp Cell Res. 1999;253(2):733-6.
[3] Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145-7.
[4] Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, Blumenthal PD, Huggins GR, Gearhart JD. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A. 1998;95(23):13726-31.
[5] Annas GJ, Caplan A, Elias S. Stem cell politics, ethics and medical progress. Nat Med. 1999;5(12):1339-41.
[6] Sukhikh GT. Transplantation of the fetal cells in medicine: present and future. Biull Eksp Biol Med. 1998;126(1):3-13.
[7] Vogel G. Cell biology. Stem cells: new excitement, persistent questions. Science. 2000;290(5497):1672-4.
[8] Shumakov VI, Blyumkin VI, Skaletskiy NN. Transplantation of islet. M., 1995.
[9] Gupta S, Yerneni PR, Vemuru RP, Lee CD, Yellin EL, Bhargava KK. Studies on the safety of intrasplenic hepatocyte transplantation: relevance to ex vivo gene therapy and liver repopulation in acute hepatic failure. Hum Gene Ther. 1993;4(3):249-57.
[10] Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2000;97(21):11307-12.
[11] McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, Gottlieb DI, Choi DW. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med. 1999;5(12):1410-2.
[12] Svendsen CN, Smith AG. New prospects for human stem-cell therapy in the nervous system. Trends Neurosci. 1999;22(8):357-64.
[13] Gluzman DF, Abramenko IV, Sklyarenko LM, Nadgornaya VA. Hematopoietic stem cells and progenitor cells of myelopoiesis. Lab. diagnosis of hematologic diseases. Kiev: MORION, 1998:25-41.
[14] Chertkov IL, Drize NI. How is the maintenance of the hematopoietic system. Gematol Transfuziol. 1998; 4: 3.
[15] Prindul G. Hematopoiesis in the yolk sac. Gematol Transfuziol. 1998; 3: 14.
[16] Nikolaenko NS. Embryonic stem cells in culture and their lineage (brief overview). Cell culture. St. Petersburg: JSC "Poznanie" 2001;24-7.
[17] Simmons PJ, Torok-Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood. 1991;78(11):2848-53.
[18] Shamblott MJ, Axelman J, Littlefield JW, Blumenthal PD, Huggins GR, Cui Y, Cheng L, Gearhart JD. Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci U S A. 2001;98(1):113-8.
[19] Huang S, Terstappen LW. Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells. Nature. 1992 Dec 24-31;360(6406):745-9.
[20] Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A. 1990;87(9):3584-8.
[21] Audet J, Zandstra PW, Eaves CJ, Piret JM. Advances in hematopoietic stem cell culture. Curr Opin Biotechnol. 1998;9(2):146-51.
[22] D'Arena G, Musto P, Cascavilla N, Carotenuto M. Thy-1 (CDw90) and c-kit receptor (CD117) expression on CD34+ hematopoietic progenitor cells: a five dimensional flow cytometric study. Haematologica. 1998;83(7):587-92.
[23] Chertkov IL, Vorob'ev AI. [Present-day concept of hematopoiesis]. Probl Gematol Pereliv Krovi. 1973;18(10):3-13.
[24] Math? G, Dantchev D, Pouillart P, Florentin I. [From hematology with microscope to hematology without microscope]. Nouv Presse Med. 1972;1(46):3135-40.
[25] Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell. 1994;76(2):253-62.
[26] Roeder I, de Haan G, Engel C, Nijhof W, Dontje B, Loeffler M. Interactions of erythropoietin, granulocyte colony-stimulating factor, stem cell factor, and interleukin-11 on murine hematopoiesis during simultaneous administration. Blood. 1998;91(9):3222-9.
[27] Matsunaga T, Kato T, Miyazaki H, Ogawa M. Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells: comparison with the effects of FLT3/FLK-2 ligand and interleukin-6. Blood. 1998;92(2):452-61.
[28] Lyman SD, Jacobsen SE. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 1998;91(4):1101-34.
[29] Lauffenburger DA, Chu L, French A, Oehrtman G, Reddy C, Wells A, Niyogi S, Wiley HS. Engineering dynamics of growth factors and other therapeutic ligands. Biotechnol Bioeng. 1996;52(1):61-80.
[30] Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90(4):1345-64.
[31] Weimar IS, Miranda N, Muller EJ, Hekman A, Kerst JM, de Gast GC, Gerritsen WR. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp Hematol. 1998;26(9):885-94.
[32] Brugger W, M?cklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood. 1993;81(10):2579-84.
[33] Ga?a MD, Pickering JA, Arthur MJ, Benyon RC. Human and rat hepatic stellate cells produce stem cell factor: a possible mechanism for mast cell recruitment in liver fibrosis. J Hepatol. 1999;30(5):850-8.
[34] Fletcher FA, Williams DE, Maliszewski C, Anderson D, Rives M, Belmont JW. Murine leukemia inhibitory factor enhances retroviral-vector infection efficiency of hematopoietic progenitors. Blood. 1990;76(6):1098-103.
[35] Bruno E, Cooper RJ, Wilson EL, Gabrilove JL, Hoffman R. Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood. 1993;82(2):430-5.
[36] Matsunaga T, Hirayama F, Yonemura Y, Murray R, Ogawa M. Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: transduction of the negative signals by betac and betaIL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor. Blood. 1998;92(3):901-7.
[37] Merchav S, Tatarsky I, Hochberg Z. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. J Clin Invest. 1988;81(3):791-7.
[38] Kmiecik TE, Keller JR, Rosen E, Vande Woude GF. Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells. Blood. 1992;80(10):2454-7.
[39] Matsunaga T, Kato T, Miyazaki H, Ogawa M. Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells: comparison with the effects of FLT3/FLK-2 ligand and interleukin-6. Blood. 1998;92(2):452-61.
[40] Broxmeyer HE. Suppressor cytokines and regulation of myelopoiesis. Biology and possible clinical uses. Am J Pediatr Hematol Oncol. 1992 Spring;14(1):22-30.
[41] Jacobsen SE, Ruscetti FW, Dubois CM, Lee J, Boone TC, Keller JR. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood. 1991;77(8):1706-16.
[42] Nathan DH, Sieff CA. [Regulation of hematopoiesis]. Gematol Transfuziol. 1994;39(2):3-10.
[43] D'Amore PA. Kissing cousins-evidence for a common vascular cell precursor. Nat Med. 2000;6(12):1323-4.
[44] Momma S, Johansson CB, Fris?n J. Get to know your stem cells. Curr Opin Neurobiol. 2000;10(1):45-9.
[45] Br?stle O, Spiro AC, Karram K, Choudhary K, Okabe S, McKay RD. In vitro-generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci U S A. 1997;94(26):14809-14.
[46] Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. Embryonic stem cells express neuronal properties in vitro. Dev Biol. 1995;168(2):342-57.
[47] Reeves RH, Yao J, Crowley MR, Buck S, Zhang X, Yarowsky P, Gearhart JD, Hilt DC. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc Natl Acad Sci U S A. 1994;91(12):5359-63.
[48] Ronfard V, Rives JM, Neveux Y, Carsin H, Barrandon Y. Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation. 2000;70(11):1588-98.
[49] Pellegrini G, Ranno R, Stracuzzi G, Bondanza S, Guerra L, Zambruno G, Micali G, De Luca M. The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation. 1999;68(6):868-79.
[50] Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997;385(6619):810-3.